摘要
目的:探讨沙库巴曲缬沙坦钠联合稳心颗粒治疗高血压并发阵发性心房颤动的临床疗效及其对心脏电生理结构的影响.方法:连续入选2021年10月至2022年11月在我院诊治的高血压并发阵发性房颤患者116例,按随机数字分组法分为稳心颗粒组(常规降压治疗的基础上采用稳心颗粒治疗)和联合治疗组(常规降压治疗的基础上,采用沙库巴曲缬沙坦钠联合稳心颗粒治疗)各58例,均连续治疗6个月.比较两组患者治疗前后临床症状评分、房颤负荷、P波持续时间、P波离散度、左房内径(LAD)、左室舒张末内径(LVEDd)、左室射血分数(LVEF)的差异.结果:治疗后,与稳心颗粒组比较,联合治疗组的临床症状评分[(1.66±0.69)分比(1.40± 0.53)分]、房颤负荷[4.43(1.65)％比 1.62(3.50)％]、P 波持续时间[(112.17±6.46)ms 比(109.29± 8.59)ms]、P 波离散度[(32.47±8.11)ms 比(29.02±7.49)ms]及 LAD[(34.83±3.41)mm 比(33.40± 3.74)mm]均显著降低(P＜0.05或＜0.01),而LVEDd及LVEF无显著差异(P均＞0.05).结论:沙库巴曲缬沙坦钠联合稳心颗粒能显著改善高血压并发阵发性房颤患者的临床症状及房颤负荷,降低房颤易感性,抑制心房电重构及结构重构.
Abstract
Objective:To explore therapeutic effect of sacubitril valsartan sodium combined with Wenxin granule in the treatment of hypertension complicated with paroxysmal atrial fibrillation(AF)and its effect on cardiac electro-physiological structure.Methods:A total of 116 patients with hypertension and paroxysmal atrial fibrillation treated in our hospital from Oct 2021 to Nov 2022 were consecutively selected.According to random number table,they were divided into Wenxin granule group(received Wenxin granule treatment based on routine antihypertensive ther-apy)and combined treatment group(received sacubitril valsartan sodium combined Wenxin granule therapy based on routine antihypertensive therapy)with 58 cases in each group,and both groups were consecutively treated for six months.Clinical symptom score,AF burden,P wave duration,P wave dispersion,left atrial diameter(LAD),left ventricular end-diastolic diameter(LVEDd)and left ventricular ejection fraction(LVEF)were compared between two groups before and after treatment.Results:After treatment,compared with Wenxin granule group,there were significant reductions in clinical symptom score[(1.66±0.69)scores vs.(1.40±0.53)scores],AF burden[4.43(1.65)％vs.1.62(3.50)％],P wave duration[(112.17±6.46)ms vs.(109.29±8.59)ms],P wave dispersion[(32.47±8.11)ms vs.(29.02±7.49)ms]and LAD[(34.83±3.41)mm vs.(33.40±3.74)mm]in combined treatment group(P＜0.05 or＜0.01).There were no significant difference in LVEDd and LVEF between two groups,P＞0.05 both.Conclusion:Sacubitril valsartan sodium combined with Wenxin granule can significantly im-prove clinical symptoms and atrial fibrillation burden,reduce the susceptibility to atrial fibrillation,and inhibit atrial electrical remodeling and structural remodeling in patients with hypertension complicated with paroxysmal atrial fi-brillation.
维普
万方数据